Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bosch

Showing results (911-920 of 1,009) with videos related to

Pageof 101
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3)Robert S Wallis, Robert Kalayjian, Jeffrey M Jacobson, et al.
Journal of Viral Hepatitis|March 16, 2017
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertensionN Afdhal, G T Everson, J L Calleja, et al.
The Journal of Infectious Diseases|February 10, 2023
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral TherapyRajesh T Gandhi, Ronald J Bosch, Hanna Mar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infectionNancie M Archin, Naveen K Vaidya, Joann D Kuruc, et al.
The Journal of Infectious Diseases|November 17, 2006
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024)J Michael Kilby, R Pat Bucy, Donna Mildvan, et al.
JAMA|September 28, 2006
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infectionBenigno Rodríguez, Ajay K Sethi, Vinay K Cheruvu, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Long-term prognostic value of a comprehensive assessment of cardiac magnetic resonance indexes after an ST-segment elevation myocardial infarctionPilar Merlos, Maria P López-Lereu, Jose V Monmeneu, et al.
AIDS (London, England)|June 22, 2022
No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ARTAdam R Ward, Allison S Thomas, Eva M Stevenson, et al.
The Journal of Infectious Diseases|March 13, 2018
Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ARTMonica Gandhi, Rajesh T Gandhi, Andrei Stefanescu, et al.
European Journal of Human Genetics : EJHG|May 14, 2009
A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities: test arrays firstAntoinet C J Gijsbers, Janet Y K Lew, Cathy A J Bosch, et al.
Pageof 101

Showing results (911-920 of 1,009) with videos related to

Sort By:
Pageof 101
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3)Robert S Wallis, Robert Kalayjian, Jeffrey M Jacobson, et al.
Journal of Viral Hepatitis|March 16, 2017
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertensionN Afdhal, G T Everson, J L Calleja, et al.
The Journal of Infectious Diseases|February 10, 2023
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral TherapyRajesh T Gandhi, Ronald J Bosch, Hanna Mar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infectionNancie M Archin, Naveen K Vaidya, Joann D Kuruc, et al.
The Journal of Infectious Diseases|November 17, 2006
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024)J Michael Kilby, R Pat Bucy, Donna Mildvan, et al.
JAMA|September 28, 2006
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infectionBenigno Rodríguez, Ajay K Sethi, Vinay K Cheruvu, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Long-term prognostic value of a comprehensive assessment of cardiac magnetic resonance indexes after an ST-segment elevation myocardial infarctionPilar Merlos, Maria P López-Lereu, Jose V Monmeneu, et al.
AIDS (London, England)|June 22, 2022
No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ARTAdam R Ward, Allison S Thomas, Eva M Stevenson, et al.
The Journal of Infectious Diseases|March 13, 2018
Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ARTMonica Gandhi, Rajesh T Gandhi, Andrei Stefanescu, et al.
European Journal of Human Genetics : EJHG|May 14, 2009
A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities: test arrays firstAntoinet C J Gijsbers, Janet Y K Lew, Cathy A J Bosch, et al.
Pageof 101